Annual review of patients with sleep apnea/hypopnea syndrome--a pragmatic randomised trial of nurse home visit versus consultant clinic review

S. Palmer, Sivasubramaniam Selvaraj, Liesl Marten Osman, G. Hulks, David John Godden, C. Dunn, John Alexander Cairns, D. Franklin

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: This pragmatic randomised, controlled trial investigated annual review of patients with sleep apnea/hypopnea syndrome (SAHS). Clinical outcomes and costs were compared for consultant clinic review versus specialist nurse home visit.

Method: One hundred and seventy-four patients were 7randomised to annual review by consultant clinic appointment or by specialist nurse home visit. SAHS symptoms. Epworth score, hospital anxiety and depression scale (HADS), Short Form-36 (SF-36) and hours of use of constant positive airway pressure (CPAP) were measured before and 3 months after review. The costs and patient preference for review were determined.

Results: After review, both groups significantly increased CPAP use (mean (SD) increase: nurse, 0.66 (1.71) h; consultant, 0.45 (1.69) h) and reduced symptom scores (nurse, - 2 (7); consultant, - 3 (9)), compared to baseline. There were no differences between groups in these improvements, or in HADS or SF-36 scores. Average duration of a nurse home visit, excluding travel time, was 26 (6) min. Total NHS cost per visit was pound52.26 (49.85) ($83.62 (79.76)), of which pound6.57 (1.43) ($10.51 (2.29)) reflected time spent with the patient and the remainder was travel cost. Average duration of consultant review was 10 (6) min, total NHS cost pound6.21 (3.99) ($9.94 (6.38)). However, the cost to the patient of attending the clinic was pound23.63 (23.21) ($37.81 (37.13)). Patient preference for review was nurse 16%, consultant 19%, and no preference 65%.

Conclusion: Following annual review, use of CPAP increased and symptoms improved. Outcomes were similar for consultant and nurse led review. Home visits were expensive for the healthcare provider, whereas clinic attendance incurred substantial costs to the patient. The majority of patients would accept nurse review for their sleep apnea management. (C) 2003 Elsevier B.V. All rights reserved.

Original languageEnglish
Pages (from-to)61-65
Number of pages4
JournalSleep Medicine
Volume5
Issue number1
DOIs
Publication statusPublished - 2004

Keywords

  • sleep apnea syndrome
  • CPAP
  • quality of life
  • symptoms
  • economics
  • outpatient review
  • APNEA
  • SCALE

Cite this

Annual review of patients with sleep apnea/hypopnea syndrome--a pragmatic randomised trial of nurse home visit versus consultant clinic review. / Palmer, S.; Selvaraj, Sivasubramaniam; Osman, Liesl Marten; Hulks, G.; Godden, David John; Dunn, C.; Cairns, John Alexander; Franklin, D.

In: Sleep Medicine, Vol. 5, No. 1, 2004, p. 61-65.

Research output: Contribution to journalArticle

Palmer, S. ; Selvaraj, Sivasubramaniam ; Osman, Liesl Marten ; Hulks, G. ; Godden, David John ; Dunn, C. ; Cairns, John Alexander ; Franklin, D. / Annual review of patients with sleep apnea/hypopnea syndrome--a pragmatic randomised trial of nurse home visit versus consultant clinic review. In: Sleep Medicine. 2004 ; Vol. 5, No. 1. pp. 61-65.
@article{718756e4e02343c4aa25d7142f0d2eb5,
title = "Annual review of patients with sleep apnea/hypopnea syndrome--a pragmatic randomised trial of nurse home visit versus consultant clinic review",
abstract = "Background: This pragmatic randomised, controlled trial investigated annual review of patients with sleep apnea/hypopnea syndrome (SAHS). Clinical outcomes and costs were compared for consultant clinic review versus specialist nurse home visit.Method: One hundred and seventy-four patients were 7randomised to annual review by consultant clinic appointment or by specialist nurse home visit. SAHS symptoms. Epworth score, hospital anxiety and depression scale (HADS), Short Form-36 (SF-36) and hours of use of constant positive airway pressure (CPAP) were measured before and 3 months after review. The costs and patient preference for review were determined.Results: After review, both groups significantly increased CPAP use (mean (SD) increase: nurse, 0.66 (1.71) h; consultant, 0.45 (1.69) h) and reduced symptom scores (nurse, - 2 (7); consultant, - 3 (9)), compared to baseline. There were no differences between groups in these improvements, or in HADS or SF-36 scores. Average duration of a nurse home visit, excluding travel time, was 26 (6) min. Total NHS cost per visit was pound52.26 (49.85) ($83.62 (79.76)), of which pound6.57 (1.43) ($10.51 (2.29)) reflected time spent with the patient and the remainder was travel cost. Average duration of consultant review was 10 (6) min, total NHS cost pound6.21 (3.99) ($9.94 (6.38)). However, the cost to the patient of attending the clinic was pound23.63 (23.21) ($37.81 (37.13)). Patient preference for review was nurse 16{\%}, consultant 19{\%}, and no preference 65{\%}.Conclusion: Following annual review, use of CPAP increased and symptoms improved. Outcomes were similar for consultant and nurse led review. Home visits were expensive for the healthcare provider, whereas clinic attendance incurred substantial costs to the patient. The majority of patients would accept nurse review for their sleep apnea management. (C) 2003 Elsevier B.V. All rights reserved.",
keywords = "sleep apnea syndrome, CPAP, quality of life, symptoms, economics, outpatient review, APNEA, SCALE",
author = "S. Palmer and Sivasubramaniam Selvaraj and Osman, {Liesl Marten} and G. Hulks and Godden, {David John} and C. Dunn and Cairns, {John Alexander} and D. Franklin",
year = "2004",
doi = "10.1016/S1389-9457(03)00166-7",
language = "English",
volume = "5",
pages = "61--65",
journal = "Sleep Medicine",
issn = "1389-9457",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Annual review of patients with sleep apnea/hypopnea syndrome--a pragmatic randomised trial of nurse home visit versus consultant clinic review

AU - Palmer, S.

AU - Selvaraj, Sivasubramaniam

AU - Osman, Liesl Marten

AU - Hulks, G.

AU - Godden, David John

AU - Dunn, C.

AU - Cairns, John Alexander

AU - Franklin, D.

PY - 2004

Y1 - 2004

N2 - Background: This pragmatic randomised, controlled trial investigated annual review of patients with sleep apnea/hypopnea syndrome (SAHS). Clinical outcomes and costs were compared for consultant clinic review versus specialist nurse home visit.Method: One hundred and seventy-four patients were 7randomised to annual review by consultant clinic appointment or by specialist nurse home visit. SAHS symptoms. Epworth score, hospital anxiety and depression scale (HADS), Short Form-36 (SF-36) and hours of use of constant positive airway pressure (CPAP) were measured before and 3 months after review. The costs and patient preference for review were determined.Results: After review, both groups significantly increased CPAP use (mean (SD) increase: nurse, 0.66 (1.71) h; consultant, 0.45 (1.69) h) and reduced symptom scores (nurse, - 2 (7); consultant, - 3 (9)), compared to baseline. There were no differences between groups in these improvements, or in HADS or SF-36 scores. Average duration of a nurse home visit, excluding travel time, was 26 (6) min. Total NHS cost per visit was pound52.26 (49.85) ($83.62 (79.76)), of which pound6.57 (1.43) ($10.51 (2.29)) reflected time spent with the patient and the remainder was travel cost. Average duration of consultant review was 10 (6) min, total NHS cost pound6.21 (3.99) ($9.94 (6.38)). However, the cost to the patient of attending the clinic was pound23.63 (23.21) ($37.81 (37.13)). Patient preference for review was nurse 16%, consultant 19%, and no preference 65%.Conclusion: Following annual review, use of CPAP increased and symptoms improved. Outcomes were similar for consultant and nurse led review. Home visits were expensive for the healthcare provider, whereas clinic attendance incurred substantial costs to the patient. The majority of patients would accept nurse review for their sleep apnea management. (C) 2003 Elsevier B.V. All rights reserved.

AB - Background: This pragmatic randomised, controlled trial investigated annual review of patients with sleep apnea/hypopnea syndrome (SAHS). Clinical outcomes and costs were compared for consultant clinic review versus specialist nurse home visit.Method: One hundred and seventy-four patients were 7randomised to annual review by consultant clinic appointment or by specialist nurse home visit. SAHS symptoms. Epworth score, hospital anxiety and depression scale (HADS), Short Form-36 (SF-36) and hours of use of constant positive airway pressure (CPAP) were measured before and 3 months after review. The costs and patient preference for review were determined.Results: After review, both groups significantly increased CPAP use (mean (SD) increase: nurse, 0.66 (1.71) h; consultant, 0.45 (1.69) h) and reduced symptom scores (nurse, - 2 (7); consultant, - 3 (9)), compared to baseline. There were no differences between groups in these improvements, or in HADS or SF-36 scores. Average duration of a nurse home visit, excluding travel time, was 26 (6) min. Total NHS cost per visit was pound52.26 (49.85) ($83.62 (79.76)), of which pound6.57 (1.43) ($10.51 (2.29)) reflected time spent with the patient and the remainder was travel cost. Average duration of consultant review was 10 (6) min, total NHS cost pound6.21 (3.99) ($9.94 (6.38)). However, the cost to the patient of attending the clinic was pound23.63 (23.21) ($37.81 (37.13)). Patient preference for review was nurse 16%, consultant 19%, and no preference 65%.Conclusion: Following annual review, use of CPAP increased and symptoms improved. Outcomes were similar for consultant and nurse led review. Home visits were expensive for the healthcare provider, whereas clinic attendance incurred substantial costs to the patient. The majority of patients would accept nurse review for their sleep apnea management. (C) 2003 Elsevier B.V. All rights reserved.

KW - sleep apnea syndrome

KW - CPAP

KW - quality of life

KW - symptoms

KW - economics

KW - outpatient review

KW - APNEA

KW - SCALE

U2 - 10.1016/S1389-9457(03)00166-7

DO - 10.1016/S1389-9457(03)00166-7

M3 - Article

VL - 5

SP - 61

EP - 65

JO - Sleep Medicine

JF - Sleep Medicine

SN - 1389-9457

IS - 1

ER -